C Hu

Researcher
2 articles (0.01 seconds)
FDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants…
On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's Spravato (Esketamine) nasal spray as a "monotherapy" treatment for major depressive disorder.
Science & Technology
boingboing.net
Tripping on psilocybin helped traumatized and depressed COVID-19 frontline healthcare workers
LIKE BOING BOING BUT NOT THE ADS?   CLICK HERE TO GO AD-FREE! At the height of the COVID-19 pandemic, frontline workers—physicians, nurses, and other health professionals were under incredible stress and…
Science & Technology
boingboing.net